Lv51
854 积分 2024-02-29 加入
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
1小时前
待确认
A reality check for autoimmune CAR T cells
11天前
已完结
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
2个月前
已完结
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
2个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
2个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
2个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
2个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
2个月前
已完结
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
2个月前
已完结
A Scoping Review of the Epidemiology of Systemic Sclerosis and Its Organ Manifestations: 2018–2024
2个月前
已完结
皖公网安备34019202002308
